Prognostic factors for first recurrence in patients with retroperitoneal sarcoma

• Published in: Urologic oncology Vol. 24; no. 2; pp. 94 - 96
• Main Authors: Avancès, Christophe, Mottet, Nicolas, Mahatmat, Aba, Chapuis, Eliette, Serre, Isabelle, Culine, Stéphane
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01-03-2006; Elsevier Science
• Subjects: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Complete excision; Female; Follow-Up Studies; Humans; Male; Medical sciences; Middle Aged; Multivariate analysis; Neoplasm Recurrence, Local - epidemiology; Nephrology. Urinary tract diseases; Prognosis; Prognostic factors; Retroperitoneal Neoplasms - epidemiology; Retroperitoneal sarcoma; Sarcoma - epidemiology; Surgery; Tumor grade; Tumors; Retroperitoneal sarcoma; Complete excision; Multivariate analysis; Tumor grade; Surgery; Prognostic factors; Histological grading; Human; Relapse; Nephrology; Prognosis; Excision; Complete; Soft tissue sarcoma; Retroperitoneal disease; Malignant tumor; Urology; Cancerology; Treatment; Abdominal disease
• ISSN: 1078-1439; 1873-2496
• DOI: 10.1016/j.urolonc.2005.09.004

Retroperitoneal sarcomas are characterized by a high local recurrence rate despite optimal surgical treatment. The definition of prognostic factors for recurrence could help offer high-risk patients a closer follow-up and a multidisciplinary therapeutic approach.
A cohort of 40 patients treated for a primary retroperitoneal sarcoma was retrospectively analyzed. Median follow-up was 24 months. Patient (sex and age), tumor (maximal size, histologic type, tumor localization, and histologic grade), and treatment (complete vs. incomplete surgery) characteristics were included in univariate and multivariate prognostic factor analyses.
After a median follow-up of 24 months (range 3−121), the overall recurrence rate was 65%. Median time between initial surgery and recurrence was 15 months (range 11.5−29.5). In univariate analysis, surgical positive margins (
P = 0.011), bilateral tumors (
P = 0.0034), nonliposarcoma histologic subtypes (
P = 0.043), and a high histologic grade (
P = 0.0072) were associated with an increased recurrence rate. All these factors except the histologic subtypes retained an independent prognostic value in the multivariate analysis. Death was strongly related to recurrence (
P = 0.0033).
The optimal treatment of patients with primary retroperitoneal sarcoma should be based on radical surgery, with en bloc organ resection if necessary, to minimize the risk of positive margins. In high-risk patients, close follow-up is mandatory to offer optimal subsequent surgical procedures. The impact of a multidisciplinary therapeutic approach remains to be proved.